An observational study in Bipolar Disorder, sponsored by Mental Health Services in the Capital Region, Denmark. Active, not recruiting at 1 site in Denmark. Open to participants aged 16 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-19.
Sponsored by Mental Health Services in the Capital Region, Denmark · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 49 studies in Bipolar Disorder with a site in Denmark — 13 open to participants now, 17 under way, 1 of them phase 3. Bipolar Disorder · Denmark.
Among the 49 studies in Bipolar Disorder with a site in Denmark, this one is the only one that started in 2016, is one of 7 observational ones, reaches primary completion later than 6 of the 16 other live ones, and was the 17th registered.
1,687 studies on the registry are indexed under Bipolar Disorder; 268 are open to participants now.
Browse Bipolar Disorder studies →13 of the 49 studies in Bipolar Disorder with a site in Denmark are open now. Recruiting first, the newest first:
Lars Vedel Kessing · Sites in Denmark
Ages 18–70
Anders Jørgensen · Sites in Denmark
Ages 18+
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital · Sites in Denmark
Ages 18–60
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital · Sites in Denmark
Ages 35–75
Bristol-Myers Squibb · Sites in Denmark, United States, Argentina and 10 more countries
Ages 18–65
A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →
Of the 207 Bipolar Disorder studies recruiting now, 60 (29%) set no upper age limit and 134 (65%) stop at 75 or younger; 38 take children under 18; 51 take healthy volunteers.
This study: 16 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
49 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 1 started in 2016.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 700 is above the median of 158 across 349 observational studies indexed under Bipolar Disorder.
Median enrollment 134 across the 42 interventional studies, 93 across the 7 observational. Of the 30 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 49 have an industry lead sponsor. The 10 most frequent:
Mental Health Services in the Capital Region, Denmark is the lead sponsor of 49 studies on the registry; 8 are open to participants now.
Mental Health Services in the Capital Region, Denmark has 9 studies filed under Bipolar Disorder — fewer than ten, so there is no comparison to draw.
6 of the studies in Bipolar Disorder with a site in Denmark that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07140913Phase 3Bristol-Myers SquibbA Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine | 2027-06-28 |
| NCT02888262Mental Health Services in the Capital Region, DenmarkThe Bipolar Illness Onset Study (the BIO Study) | 2026-12 |
| NCT06624462Bjorn H. EbdrupEffectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care Clinic | 2026-12 |
| NCT07082777University of AarhusRecovery in Telling Life Stories | 2027-04-01 |
| NCT07404085Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg HospitalEpigenetic Enhancement of Cognitive Training in Aging Mood and Schizophrenia Spectrum Disorder Populations | 2027-07-01 |
Add all 6 to your calendar (.ics) → With an account.
Among the 49 studies in Bipolar Disorder with a site in Denmark, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This longitudinal study aims to identify 1) a composite blood-based biomarker, 2) a composite electronic Smartphone-based biomarker and 3) a neurocognitive signature for bipolar disorder
The study will include 300 patients with newly diagnosed/first episode bipolar disorder, 200 healthy siblings or child family members and 100 healthy individuals without a family history of affective disorder. All individuals will be investigated with repeated blood tests, Smartphone recordings, neuropsychological tests and brain imaging during a five to ten year study period.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients with newly diagnosed bipolar disorder
Healthy first generation relatives to the included patients
Healthy individuals without a family history of psychiatric disorders
Composite blood based biomarker
Time frame: 5 years
Composite smartphone based biomarker including self reported and smartphone generated data
Composite smartphone based biomarker including 1) self reported data and 2) smartphone generated data on physical activity 3) social activity and 4) voice features collected during phone calls
Time frame: 5 years
Composite neurocognitive marker including "Cold" and "Hot" cognition.
Composite neurocognitive marker including "Cold" cognition assessed with neuropsychological tests probing verbal memory and executive function and "Hot" cognition assessed with a comprehensive computerized battery of cognitive tests probing (i) emotional processing (ii) reward processing and (iii) emotional regulation.
Time frame: 5 years
Plan to share: No
Started Jan 2016 (actual). Primary completion is estimated for Dec 2026, 131 months after the start.
Of 95 non-industry observational studies under Bipolar Disorder, half reached primary completion within 65 months of starting (the median), counting those still running; a quarter within 39 and three quarters within 119. This study's planned 131 months is above that.
Counting every sponsor, half of 105 studies reached it within 64 months; a quarter within 31 and three quarters within 119.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mental Health Services in the Capital Region, Denmark